Gilead Sciences Revenue 2006-2019 | GILD

Gilead Sciences annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Gilead Sciences revenue for the quarter ending September 30, 2019 was $5.604B, a 0.14% increase year-over-year.
  • Gilead Sciences revenue for the twelve months ending September 30, 2019 was $22.365B, a 0.38% increase year-over-year.
  • Gilead Sciences annual revenue for 2018 was $22.127B, a 15.24% decline from 2017.
  • Gilead Sciences annual revenue for 2017 was $26.107B, a 14.09% decline from 2016.
  • Gilead Sciences annual revenue for 2016 was $30.39B, a 6.89% decline from 2015.
Gilead Sciences Annual Revenue
(Millions of US $)
2018 $22,127
2017 $26,107
2016 $30,390
2015 $32,639
2014 $24,890
2013 $11,202
2012 $9,702
2011 $8,385
2010 $7,949
2009 $7,011
2008 $5,336
2007 $4,230
2006 $3,026
2005 $2,028
Gilead Sciences Quarterly Revenue
(Millions of US $)
Q3 2019 $5,604
Q2 2019 $5,685
Q1 2019 $5,281
Q4 2018 $5,795
Q3 2018 $5,596
Q2 2018 $5,648
Q1 2018 $5,088
Q4 2017 $5,949
Q3 2017 $6,512
Q2 2017 $7,141
Q1 2017 $6,505
Q4 2016 $7,320
Q3 2016 $7,500
Q2 2016 $7,776
Q1 2016 $7,794
Q4 2015 $8,506
Q3 2015 $8,295
Q2 2015 $8,244
Q1 2015 $7,594
Q4 2014 $7,314
Q3 2014 $6,042
Q2 2014 $6,535
Q1 2014 $4,999
Q4 2013 $3,120
Q3 2013 $2,783
Q2 2013 $2,767
Q1 2013 $2,532
Q4 2012 $2,588
Q3 2012 $2,427
Q2 2012 $2,405
Q1 2012 $2,282
Q4 2011 $2,200
Q3 2011 $2,122
Q2 2011 $2,137
Q1 2011 $1,926
Q4 2010 $1,999
Q3 2010 $1,938
Q2 2010 $1,927
Q1 2010 $2,086
Q4 2009 $2,032
Q3 2009 $1,801
Q2 2009 $1,647
Q1 2009 $1,530
Q4 2008 $1,428
Q3 2008 $1,371
Q2 2008 $1,278
Q1 2008 $1,258
Q4 2007 $1,095
Q3 2007 $1,059
Q2 2007 $1,048
Q1 2007 $1,028
Q4 2006 $899
Q3 2006 $749
Q2 2006 $685
Q1 2006 $693
Q4 2005 $609
Q3 2005 $493
Q2 2005 $495
Q1 2005 $430
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $83.209B $22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.667B 16.20
CSL (CSLLY) Australia $87.267B 0.00
Vertex Pharmaceuticals (VRTX) United States $56.311B 57.47
Biogen (BIIB) United States $53.561B 9.19
Illumina (ILMN) United States $47.734B 52.37
Regeneron Pharmaceuticals (REGN) United States $41.329B 18.10
Alexion Pharmaceuticals (ALXN) United States $24.435B 12.07
Incyte (INCY) United States $19.711B 45.76
Seattle Genetics (SGEN) United States $19.516B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.617B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.401B 0.00
Genmab (GNMSF) Denmark $13.473B 59.51
Alnylam Pharmaceuticals (ALNY) United States $13.127B 0.00
Galapagos (GLPG) Belgium $11.469B 29.55
Exact Sciences (EXAS) United States $11.321B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.822B 51.94
Sarepta Therapeutics (SRPT) United States $9.843B 0.00
QIAGEN (QGEN) Netherlands $9.282B 30.26
Amarin (AMRN) Ireland $8.616B 0.00
BeiGene (BGNE) Cayman Islands $8.453B 0.00
Bio-Techne Corp (TECH) United States $8.119B 54.34
BioNTech SE (BNTX) Germany $7.342B 0.00
Guardant Health (GH) United States $7.127B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.829B 0.00
Medicines (MDCO) United States $6.714B 0.00
Reata Pharmaceuticals (RETA) United States $6.259B 0.00
Moderna (MRNA) United States $6.205B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.151B 15.64
ARGENX SE-ADR (ARGX) Netherlands $5.987B 0.00
Exelixis (EXEL) United States $5.415B 15.23
Bluebird Bio (BLUE) United States $4.966B 0.00
Ascendis Pharma (ASND) Denmark $4.854B 0.00
Repligen (RGEN) United States $4.612B 83.58
China Biologic Products (CBPO) China $4.605B 25.94
MorphoSys AG (MOR) Germany $4.485B 0.00
Mirati Therapeutics (MRTX) United States $4.427B 0.00
Spark Therapeutics (ONCE) United States $4.266B 0.00
Immunomedics (IMMU) United States $3.997B 0.00
Adaptive Biotechnologies (ADPT) United States $3.755B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.737B 0.00
Blueprint Medicines (BPMC) United States $3.653B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.608B 0.00
Alkermes (ALKS) Ireland $3.287B 0.00
UniQure (QURE) Netherlands $3.227B 0.00
MyoKardia (MYOK) United States $3.083B 0.00
Genmab (GMAB) Denmark $2.854B 5.88
Halozyme Therapeutics (HALO) United States $2.781B 0.00
NeoGenomics (NEO) United States $2.758B 146.78
Emergent Biosolutions (EBS) United States $2.683B 26.65
Acceleron Pharma (XLRN) United States $2.679B 0.00
Zai Lab (ZLAB) China $2.502B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.469B 0.00
Amicus Therapeutics (FOLD) United States $2.403B 0.00
Arena Pharmaceuticals (ARNA) United States $2.356B 5.48
RA PHARMCTL INC (RARX) United States $2.225B 0.00
Insmed (INSM) United States $2.074B 0.00
Myriad Genetics (MYGN) United States $1.903B 28.11
Ligand Pharmaceuticals (LGND) United States $1.862B 35.82
Dicerna Pharmaceuticals (DRNA) United States $1.833B 0.00
Denali Therapeutics (DNLI) United States $1.815B 0.00
Akcea Therapeutics (AKCA) United States $1.812B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.656B 0.00
Zymeworks (ZYME) Canada $1.654B 0.00
Principia Biopharma (PRNB) United States $1.630B 0.00
Epizyme (EPZM) United States $1.613B 0.00
REGENXBIO (RGNX) United States $1.606B 0.00
Editas Medicine (EDIT) United States $1.534B 0.00
Arvinas (ARVN) United States $1.435B 0.00
Fate Therapeutics (FATE) United States $1.420B 0.00
Innoviva (INVA) United States $1.394B 4.11
Alector (ALEC) United States $1.393B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.371B 0.00
Coherus BioSciences (CHRS) United States $1.299B 0.00
WAVE Life Sciences (WVE) Singapore $1.289B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.188B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Athenex (ATNX) United States $1.128B 0.00
Zealand Pharma (ZEAL) Denmark $1.015B 0.00
Pharming Group (PHGUF) Netherlands $1.013B 0.00
Sangamo Therapeutics (SGMO) United States $0.987B 0.00
Codexis (CDXS) United States $0.925B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.892B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.892B 7.50
Achillion Pharmaceuticals (ACHN) United States $0.877B 0.00
Twist Bioscience (TWST) United States $0.870B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.841B 0.00
Intellia Therapeutics (NTLA) United States $0.807B 0.00
Vericel (VCEL) United States $0.788B 294.00
MiMedx (MDXG) United States $0.782B 0.00
DBV Technologies S.A (DBVT) France $0.780B 0.00
Anika Therapeutics (ANIK) United States $0.758B 24.61
ANI Pharmaceuticals (ANIP) United States $0.739B 12.60
Heska (HSKA) United States $0.732B 186.92
Revance Therapeutics (RVNC) United States $0.721B 0.00
Intra-Cellular Therapies (ITCI) United States $0.709B 0.00
Clovis Oncology (CLVS) United States $0.705B 0.00
Adverum Biotechnologies (ADVM) United States $0.681B 0.00
Cellectis S.A (CLLS) France $0.677B 0.00
UROGEN PHARMA (URGN) United States $0.676B 0.00
Mesoblast (MESO) Australia $0.670B 0.00
Sorrento Therapeutics (SRNE) United States $0.670B 0.00
Cara Therapeutics (CARA) United States $0.663B 0.00
Cytokineticsorporated (CYTK) United States $0.629B 0.00
GENFIT S.A (GNFT) France $0.628B 0.00
Retrophin (RTRX) United States $0.616B 0.00
Kadmon Holdings (KDMN) United States $0.613B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
PHARMA MAR SA (PHMMF) Spain $0.584B 0.00
Dynavax Technologies (DVAX) United States $0.580B 0.00
AC Immune SA (ACIU) Switzerland $0.577B 13.34
BioDelivery Sciences (BDSI) United States $0.573B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Agenus (AGEN) United States $0.527B 0.00
Precision BioSciences (DTIL) United States $0.523B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.516B 3.57
Prothena (PRTA) Ireland $0.513B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.508B 0.00
Stemline Therapeutics (STML) United States $0.504B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AnaptysBio (ANAB) United States $0.427B 0.00
Avid Bioservices (CDMO) United States $0.410B 0.00
Arcus Biosciences (RCUS) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.395B 0.00
Bellus Health (BLU) Canada $0.387B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.60
AMAG Pharmaceuticals (AMAG) United States $0.378B 0.00
OSMOTICA PHARM (OSMT) United States $0.370B 0.00
Puma Biotechnology (PBYI) United States $0.365B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.344B 0.00
Gritstone Oncology (GRTS) United States $0.331B 0.00
Starpharma Holdings (SPHRY) Australia $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.325B 0.00
Cellular Biomedicine (CBMG) United States $0.321B 0.00
Kindred Biosciences (KIN) United States $0.319B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.314B 0.00
Cue Biopharma (CUE) United States $0.312B 0.00
Scholar Rock Holding (SRRK) United States $0.305B 0.00
Geron (GERN) United States $0.300B 0.00
Seres Therapeutics (MCRB) United States $0.294B 0.00
Kamada (KMDA) Israel $0.294B 8.58
Compugen (CGEN) Israel $0.290B 0.00
NantKwest (NK) United States $0.283B 0.00
MannKind (MNKD) United States $0.279B 0.00
ChromaDex (CDXC) United States $0.275B 0.00
Inovio Pharmaceuticals (INO) United States $0.272B 0.00
Exicure (XCUR) United States $0.261B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
Albireo Pharma (ALBO) United States $0.257B 0.00
IVERIC Bio (ISEE) United States $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.242B 0.00
Senesco Technologies (ELOX) United States $0.239B 0.00
Theratechnologies (THTX) Canada $0.234B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.231B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.227B 0.00
Biofrontera AG (BFRA) Germany $0.221B 0.00
Proteostasis Therapeutics (PTI) United States $0.217B 0.00
Spero Therapeutics (SPRO) United States $0.212B 0.00
XOMA (XOMA) United States $0.208B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Protagonist Therapeutics (PTGX) United States $0.199B 0.00
Syros Pharmaceuticals (SYRS) United States $0.195B 0.00
Cerecor (CERC) United States $0.195B 0.00
Affimed (AFMD) Germany $0.194B 0.00
Athersys (ATHX) United States $0.194B 0.00
ARAVIVE, INC (ARAV) United States $0.190B 0.00
Abeona Therapeutics (ABEO) United States $0.187B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
Mersana Therapeutics (MRSN) United States $0.178B 0.00
VBI Vaccines (VBIV) United States $0.174B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.158B 0.00
Five Prime Therapeutics (FPRX) United States $0.157B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Windtree Therapeutics (WINT) United States $0.151B 0.00
Alcobra (ARCT) United States $0.150B 0.00
Aptinyx (APTX) United States $0.143B 0.00
Fortress Biotech (FBIO) United States $0.139B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.138B 0.00
Arsanis (XFOR) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Prometic Life Sciences (LMNL) Canada $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
Arbutus Biopharma (ABUS) Canada $0.132B 0.00
TELA Bio (TELA) United States $0.128B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.128B 0.00
Nicox SA (NICXF) France $0.125B 0.00
Enzo Biochem (ENZ) United States $0.125B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.109B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.108B 0.00
Novavax (NVAX) United States $0.107B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.102B 0.00
Emmaus Life Sciences (EMMA) United States $0.101B 0.00
Strongbridge Biopharma (SBBP) United States $0.100B 2.67
Verastem (VSTM) United States $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Aduro Biotech (ADRO) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Acorda Therapeutics (ACOR) United States $0.085B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
OvaScience (MLND) United States $0.083B 0.00
Vaccinex (VCNX) United States $0.082B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Trevena (TRVN) United States $0.069B 0.00
Liquidia Technologies (LQDA) United States $0.068B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.061B 0.00
Catalyst Biosciences (CBIO) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.051B 0.00
Curis (CRIS) United States $0.050B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
Checkpoint Therapeutics (CKPT) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Orgenesis (ORGS) United States $0.046B 2.97
DiaMedica Therapeutics (DMAC) United States $0.045B 0.00
AquaBounty Technologies (AQB) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.041B 0.00
Alimera Sciences (ALIM) United States $0.041B 0.00
Celsion (CLSN) United States $0.037B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.035B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.030B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
BioCardia (BCDA) United States $0.028B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Soligenix (SNGX) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Entera Bio (ENTX) Israel $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
CollPlant Holdings (CLGN) Israel $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Aytu Bioscience (AYTU) United States $0.019B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
AEterna Zentaris (AEZS) United States $0.016B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Advaxis (ADXS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.003B 0.00